Dong‐Churl Suh

3.6k total citations
104 papers, 2.6k citations indexed

About

Dong‐Churl Suh is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dong‐Churl Suh has authored 104 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 20 papers in Geriatrics and Gerontology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dong‐Churl Suh's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Pharmaceutical Practices and Patient Outcomes (19 papers) and Pharmaceutical Economics and Policy (12 papers). Dong‐Churl Suh is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Pharmaceutical Practices and Patient Outcomes (19 papers) and Pharmaceutical Economics and Policy (12 papers). Dong‐Churl Suh collaborates with scholars based in United States, South Korea and United Kingdom. Dong‐Churl Suh's co-authors include Clifton R. Lacy, John B. Kostis, Myung‐Soo Lee, Edward G. Rogoff, Louise B. Russell, Evelyn R. Hermes‐DeSantis, In‐Sun Choi, Craig Plauschinat, In‐Sun Choi and Linda Flynn and has published in prestigious journals such as Diabetes Care, Stroke and The American Journal of Cardiology.

In The Last Decade

Dong‐Churl Suh

102 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong‐Churl Suh United States 26 537 416 396 330 289 104 2.6k
Joke C. Korevaar Netherlands 31 834 1.6× 537 1.3× 356 0.9× 643 1.9× 214 0.7× 138 3.2k
Peter K. K. Wong Australia 21 260 0.5× 503 1.2× 288 0.7× 296 0.9× 189 0.7× 64 3.3k
Abraham G. Hartzema United States 37 680 1.3× 534 1.3× 303 0.8× 334 1.0× 160 0.6× 113 4.4k
Grant H. Skrepnek United States 24 209 0.4× 271 0.7× 333 0.8× 199 0.6× 281 1.0× 97 1.9k
James Zhang United States 28 345 0.6× 558 1.3× 222 0.6× 540 1.6× 174 0.6× 113 2.7k
T Walley United Kingdom 31 229 0.4× 761 1.8× 258 0.7× 569 1.7× 176 0.6× 82 3.0k
Adrian R. Levy Canada 37 622 1.2× 844 2.0× 147 0.4× 405 1.2× 186 0.6× 141 4.1k
Agnès Vitry Australia 29 500 0.9× 1.0k 2.5× 654 1.7× 484 1.5× 216 0.7× 106 2.9k
Sarah L. Cutrona United States 28 369 0.7× 373 0.9× 294 0.7× 915 2.8× 108 0.4× 98 2.7k
Justine Rochon Germany 29 461 0.9× 443 1.1× 180 0.5× 520 1.6× 117 0.4× 65 3.0k

Countries citing papers authored by Dong‐Churl Suh

Since Specialization
Citations

This map shows the geographic impact of Dong‐Churl Suh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Churl Suh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Churl Suh more than expected).

Fields of papers citing papers by Dong‐Churl Suh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Churl Suh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Churl Suh. The network helps show where Dong‐Churl Suh may publish in the future.

Co-authorship network of co-authors of Dong‐Churl Suh

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Churl Suh. A scholar is included among the top collaborators of Dong‐Churl Suh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Churl Suh. Dong‐Churl Suh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahn, Jeonghoon, Iñaki Gutiérrez‐Ibarluzea, Michael Drummond, et al.. (2024). Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers. Expert Review of Pharmacoeconomics & Outcomes Research. 24(9). 1061–1066. 2 indexed citations
2.
Suh, David, et al.. (2022). Risk of Fall-Related Injuries Associated with Antidepressant Use in Elderly Patients: A Nationwide Matched Cohort Study. International Journal of Environmental Research and Public Health. 19(4). 2298–2298. 18 indexed citations
3.
Suh, David, et al.. (2018). The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study. Health and Quality of Life Outcomes. 16(1). 180–180. 25 indexed citations
4.
Suh, David, Suheon Lee, & Dong‐Churl Suh. (2018). PCN69 - BUDGET IMPACT OF SUBSTITUTING BIOSIMILAR TRASTUZUMAB (CT-P6) IN TREATING GASTRIC CANCER AND BREAST CANCER IN 28 EUROPEAN COUNTRIES. Value in Health. 21. S25–S25. 2 indexed citations
5.
Lee, Joo‐Heung, Jee‐Ho Choi, Chul Jong Park, et al.. (2018). Factors influencing quality of life in patients with psoriasis in Korea. European Journal of Dermatology. 28(5). 678–680. 1 indexed citations
6.
Henderson, Emmett R., et al.. (2017). Statin Cost Effectiveness: A Systematic Review Including The Recent Literature. Value in Health. 20(9). A616–A616. 1 indexed citations
7.
8.
Suh, Dong‐Churl, et al.. (2015). Productivity Loss Costs Attributable to Obesity in Working Patients with Diabetes in the US. Value in Health. 18(7). A604–A604. 1 indexed citations
9.
Suh, Dong‐Churl, et al.. (2013). Factors associated with warfarin discontinuation, including bleeding patterns, in atrial fibrillation patients. Current Medical Research and Opinion. 29(7). 761–771. 15 indexed citations
10.
Suh, Dong‐Churl, et al.. (2013). Impact Of Adverse Drug Events On Hospital Length Of Stay And Hospitalization Costs In Hospitals For 2003-2009 In The United States. Value in Health. 16(3). A202–A202. 3 indexed citations
11.
Spackman, Eldon, Stephen Rice, Gill Norman, et al.. (2013). Trastuzumab for the Treatment of HER2-Positive Metastatic Gastric Cancer. PharmacoEconomics. 31(3). 185–194. 36 indexed citations
12.
Suh, Dong‐Churl, Rajesh Pahwa, & Usha G. Mallya. (2012). Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia. Journal of the Neurological Sciences. 319(1-2). 24–31. 36 indexed citations
13.
Brunetti, Luigi & Dong‐Churl Suh. (2012). Medication Errors: Scope and prevention strategies. Journal of Hospital Administration. 1(2). 54–54. 11 indexed citations
14.
Gandhi, Pranav, L. Douglas Ried, I‐Chan Huang, et al.. (2011). PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUES. Value in Health. 14(3). A52–A53. 1 indexed citations
15.
Pizzi, Laura T., Eric Jutkowitz, Laura N. Gitlin, Dong‐Churl Suh, & Michael Dennis. (2011). PMH51 BASELINE RESULTS FROM BEAT THE BLUES. Value in Health. 14(3). A195–A195. 2 indexed citations
16.
Giles, Thomas D., Juan M. Aranda, Dong‐Churl Suh, et al.. (2007). Ethnic/Racial Variations in Blood Pressure Awareness, Treatment, and Control. Journal of Clinical Hypertension. 9(5). 345–354. 84 indexed citations
17.
Suh, Dong‐Churl, Simu K. Thomas, Elmira Valiyeva, Stephen Arcona, & Lien Vo. (2005). Drug Persistency of Two Cholinesterase Inhibitors. Drugs & Aging. 22(8). 695–707. 44 indexed citations
18.
Rogoff, Edward G., Myung‐Soo Lee, & Dong‐Churl Suh. (2004). “Who Done It?” Attributions by Entrepreneurs and Experts of the Factors that Cause and Impede Small Business Success. Journal of Small Business Management. 42(4). 364–376. 195 indexed citations
19.
Suh, Dong‐Churl, et al.. (2002). Application of pharmacoeconomics to formulary decision making in managed care organizations.. PubMed. 8(2). 161–9. 14 indexed citations
20.
Suh, Dong‐Churl. (2000). Consumers’ Willingness to Pay for Pharmacy Services that Reduce Risk of Medication-Related Problems. Journal of the American Pharmaceutical Association (1996). 40(6). 818–827. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joke C. Korevaar Breakdown of academic impact, for papers by Peter K. K. Wong Breakdown of academic impact, for papers by Abraham G. Hartzema Breakdown of academic impact, for papers by Grant H. Skrepnek Breakdown of academic impact, for papers by James Zhang Breakdown of academic impact, for papers by T Walley Breakdown of academic impact, for papers by Adrian R. Levy Breakdown of academic impact, for papers by Agnès Vitry Breakdown of academic impact, for papers by Sarah L. Cutrona Breakdown of academic impact, for papers by Justine Rochon
Rankless by CCL
2026